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The intracellular Gram-negative pathogen Francisella tularensis is the causative agent of
tularaemia and is prevalent in many countries in the northern hemisphere. To determine whether
the common marmoset (Callithrix jacchus) would be a suitable non-human primate model of
inhalational tularaemia, a pathophysiology study was undertaken. Ten animals were challenged
with ~10
2 c.f.u. F. tularensis strain SCHU S4 (F. tularensis subsp. tularensis). To look for trends
in the infection, pairs of animals were sacrificed at 24 h intervals between 0 and 96 h post-
challenge and blood and organs were assessed for bacteriology, pathology and haematological
and immunological parameters. The first indication of infection was a raised core temperature at
3 days post-challenge. This coincided with a number of other factors: a rapid increase in the
number of bacteria isolated from all organs, more pronounced gross pathology and
histopathology, and an increase in the immunological response. As the disease progressed,
higher bacterial and cytokine levels were detected. More extensive pathology was observed, with
multifocal lesions seen in the lungs, liver and spleen. Disease progression in the common
marmoset appears to be consistent with human clinical and pathological features of tularaemia,
indicating that this may be a suitable animal model for the investigation of novel medical
interventions such as vaccines or therapeutics.
INTRODUCTION
Francisella tularensis is a Gram-negative intracellular
pathogen and the causative agent of tularaemia. The
disease is prevalent in many countries in the northern
hemisphere and is infectious by a number of routes (Ellis
et al., 2002). Due to its high infectivity and virulence, F.
tularensis has been developed previously for use as a
bioweapon (Dennis et al., 2001) and is considered a
Category A agent on the Centers for Disease Control
and Prevention threat lists (CDC Emergency Preparedness
and Response website; http://emergency.cdc.gov/agent/
agentlist-category.asp).
A number of animal models, mainly rodents, have been
used to study disease pathogenesis, to understand the host
immunology and to assess the efficacy of various
therapeutic agents and vaccines. The majority of work to
study the pathogenesis of tularaemia has used murine
models of infection (Conlan et al., 2003; Green et al.,
2005). BALB/c mice and C57BL/6 mice are susceptible to
low doses (between 10 and 20 c.f.u.) of both F. tularensis
subsp. tularensis and F. tularensis subsp. holarctica
(formally known as type A and type B strains, respectively;
Green et al., 2005).
Despite the valuable information obtained from rodent
models, there are limitations. Generally, one main
limitation of animal models of infectious diseases is the
inability to predict human responses to pathogens or
therapeutic compounds accurately (Herodin et al., 2005).
There are advantages to using non-human primates to
model infectious diseases; for tularaemia, primates are the
only experimental animals that develop the characteristic
skin ulcers and lymphadenitis of tularaemia, whilst other
clinical features reflect human disease more readily than
rodent models. There is a need to develop robust non-
human primate models of infection to assess potential
vaccines and therapies.
Marmosets have been demonstrated to be susceptible to
tularaemia in two naturally occurring outbreaks in captive
animals (Posthaus et al., 1998; Splettstoesser et al., 2007).
Abbreviations: ALT, alanine aminotransferase; AST, aspartate amino-
transferase; NK, natural killer; Tc, core body temperature.
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mental infection in other non-human primates. We have
demonstrated previously that marmosets are susceptible to
experimental inhalational tularaemia and develop a lethal
infection (Nelson et al., 2009). The aim of the current study
was to characterize the progression of the disease in the
marmoset to determine the suitability of the species as a
model of human infection.
METHODS
Animals. Healthy, sexually mature common marmosets (Callithrix
jacchus) were obtained from the Dstl Porton Down breeding colony
and housed in female and vasectomized male pairs. Adult animals
were aged between 19 and 84 months old and weighed between 354
and 506 g at the time of challenge. The animals were allowed free
access to food and water, as well as environmental enrichment. Prior
to use in challenge studies, animals were surgically implanted
intraperitoneally with a Remo 200 device to record core body
temperature (Tc), under general anaesthesia (ketamine/medetomi-
dine/isofluorane). Data were transmitted from the devices at 10 s
intervals to locally placed antennas and relayed to receivers. Data were
analysed using eDacq software to provide a real-time and recordable
Tc. All animal studies were carried out in accordance with the UK
Animals (Scientific Procedures) Act of 1986 and the Codes of Practice
for the Housing and Care of Animals used in Scientific Procedures
1989. Following challenge with F. tularensis, all animals were handled
under UK Advisory Committee on Dangerous Pathogens animal
containment level 3 conditions within a half-suit isolator compliant
with British Standard BS5726.
Bacterial strain and culture. Glycerol stocks of F. tularensis strain
SCHU S4 were obtained from DynPort Vaccine Company LLC.
Bacteria were recovered from the vial onto blood cysteine glucose agar
(BCGA) plates and incubated at 37 uC for 24 h, prior to recovery into
PBS (pH 7.3). The OD590 of the suspension was adjusted to 0.1,
equivalent to approximately 1610
8 c.f.u. ml
21, 1 ml of which was
used to inoculate 100 ml modified cysteine partial hydrolysate broth.
The broth was shaken at 180 r.p.m. for 48 h at 37 uC. Prior to
challenge, the OD590 of the culture was adjusted to 0.1 and serially
diluted in PBS to the appropriate concentration for challenge. Viable
counts were performed by subculture onto BCGA retrospectively.
Plates were incubated at 37 uC for 72 h prior to enumeration. All
bacteriological procedures were carried out under UK Advisory
Committee on Dangerous Pathogens containment level 3 conditions
in Class 3 microbiological safety cabinets compliant with British
Standard BS5726.
Challenge. The marmosets were anaesthetized with 25 mg ketamine
kg
21 administered intramuscularly prior to exposure and were
challenged in pairs by the airborne route (Lever et al., 2008; Nelson
et al., 2009). Briefly, a Collison nebulizer containing 20 ml F.
tularensis and three drops of Antifoam 289 (Sigma) was used to
generate aerosol particles of approximately 1–3 mm. The aerosol was
conditioned in a modified Henderson apparatus (Druett, 1969).
Marmosets were placed in a head-only exposure chamber (plethys-
mograph tube) and exposed for 10 min to a dynamic aerosol
maintained at 50–55% relative humidity and 18–20 uC. The total
accumulated tidal volume for each animal during challenge was
determined by whole-body real-time plethysmography with a Fleisch
pneumotachograph (EMMS). The concentration of the aerosol cloud
was quantified after sampling from a sample port into an all-glass
impinger (AGI-30; SKU) by serial dilution and plating onto BCGA.
Characterization of the disease. Ten marmosets were challenged
in pairs with F. tularensis strain SCHU S4 by the airborne route
(Table 1). Pairs of animals were sacrificed at 0, 24, 48, 72 and 96 h
post-challenge to investigate disease progression trends. Blood was
removed from marmosets immediately after culling by cardiac
puncture for assessment of bacteraemia, clinical chemistry, haemato-
logy and immunology. Post-mortem examinations were performed
on all animals upon culling; organs were removed and assessed for
bacteriology, immunology, gross pathology and histopathology.
Bacteriology. Bacterial loads in the blood, liver, spleen, kidneys and
lungs were assessed for all animals. Sacrificed animals were dissected,
the organs were removed aseptically and the organ weight was
determined. Organs were homogenized in 5 ml PBS using cell sieves
and a plunger. Organ homogenates and blood were serially diluted in
PBS and the appropriate dilutions were subcultured onto BCGA
plates, which were incubated at 37 uC for 72 h prior to enumeration.
Counts were expressed as c.f.u. (g tissue)
21 or c.f.u. (ml blood)
21.
Cytokine and chemokine determination. Blood and organ
homogenates were also processed for immunological analysis. For
cytokine and chemokine analysis, the cell suspension supernatants
were collected and stored at 280 uC until assayed. A range of
cytokines appropriate for qualification of an innate response was
measured. The cytokines were assayed using a Cytometric Bead Array
Flex Set (BD Biosciences) according to the manufacturer’s instruc-
tions. Briefly, cytokine standards were reconstituted in assay
buffer diluent (buffered protein solution) and serially diluted. Ten
Table 1. Animal and exposure dose data
Time of
culling (h)
Gender Age
(years)
Body
weight (g)
Inhaled accumulative
volume (l)
Aerosol
concn (c.f.u. l
”1)
Inhaled
dose (c.f.u.)
0 F 4.8 374 0.8 2.9610
2 2.2610
2
M 7.0 382 1.0 2.9610
2 2.8610
2
24 F 2.2 426 1.3 1610
2 1.3610
2
M 5.0 442 1.8 1610
2 1.8610
2
48 F 2.1 506 1.5 1.6610
2 2.4610
2
M 3.8 390 1.1 1.6610
2 1.8610
2
72 F 1.6 404 2.0 8.7610
1 1.7610
2
M 2.2 394 1.1 8.7610
1 9.2610
1
96 F 1.8 354 1.0 1.6610
2 1.6610
2
M 2.2 470 0.9 1.6610
2 1.4610
2
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mixed and transferred to the assay tubes. The test sera or standard
dilutions and phycoerythrin detection reagent (50 ml) were added to
sample tubes and incubated for 2 h in the dark. The samples were
then washed with 1 ml wash buffer (PBS, protein and detergent) and
centrifuged. One millilitre of 4% paraformaldehyde was added to
each tube for fixation at 4 uC for 24 h prior to analysis. Cytokine
detection was performed by flow cytometry on a BD FACSCanto
using BD FACSDiva and FACScan software. Cytokine and chemokine
levels were expressed as pg ml
21, except for monocyte chemotactic
protein-1 (MCP-1), which was expressed as fluorescence intensities,
as, due to the failure of the standard antibody, a calibration curve was
not determined.
Cell type determination. Cell type was assessed from the fresh cell
suspension. A range of anti-human monoclonal antibodies was used
for lymphocyte staining according to the manufacturer’s concentra-
tions: anti-CD3 (clone sp34; BD Biosciences), anti-CD4 (clone
MT310; Dako), anti-CD8 (clone lt8; AbD Serotec), anti-CD11c (clone
s-hcl-3; BD Biosciences), anti-CD14 (clone m5e2; BD Biosciences),
anti-CD20 (clone B-Ly1; Dako), anti-CD27 (clone m-t271; BD
Biosciences), anti-CD56 (clone NCAM16.2; BD Biosciences) and
anti-Vc2 (15D; Endogen) stain. Single-cell homogenate or whole
blood (100 ml) was stained using these fluorescently labelled
antibodies, which have previously been reported as cross-reacting
with marmoset leukocytes (Brok et al., 2001). After staining for 40 min
at room temperature in the dark, red blood cells were lysed using
OptiLyse C (Beckman Coulter), washed and resuspended in 4%
paraformaldehyde and kept at 4 uC for 24 h before being analysed on a
six-colour BD FACSCanto II using FACSDiva software. Data for
10000 events of appropriate proportions for live leukocytes were
collected. Briefly, leukocytes were defined by appropriate location and
the following staining: CD3
+ as T cells, CD3
+ CD8
+ CD56
+ as
activated cytotoxic T cells, CD3
+ CD8
2 as CD4 T cells, CD3
+ Vc2
+
CD56
+ as activated cd T cells, CD3
+ CD56
+ CD8
2 as natural killer
(NK) T cells, CD3
2 CD56
+ as NK cells, CD14
+ CD11c
2 as
neutrophils, CD14
+ CD11c
+ as macrophages and CD20
+ as B cells.
Cell type levels were expressed as a percentage of the viable population.
Due to the small group sizes, statistical analysis was not possible. Only
increases in percentages of cells to twice that of the normal mean
(obtained from three uninfected animals) and outside the ranges are
reported.
Histopathology. Tissues were fixed in 10% neutral buffered
formalin and processed for paraffin wax embedding using standard
techniques. Thin sections (5 mm) were cut and stained with
haematoxylin and eosin for histopathological analysis.
Haematology, clinical chemistry and electrolytes. Blood was
collected at defined time points into tubes containing EDTA and key
parameters were measured by use of a laser flow cytometry-based
haematological analyser (LaserCyte; IDEXX Laboratories): total white
blood cell count, platelet count, packed cell volume (haematocrit) and
haemoglobin. Plasma (lithium heparin) concentrations of albumin,
alkaline phosphatase, total bilirubin, alanine aminotransferase (ALT),
aspartate aminotransferase (AST), creatine kinase, glucose and
creatinine were determined using a ‘dry-slide’ technology biochem-
istry analyser (VetTest; IDEXX Laboratories). An ion-selective
electrode-based electrolyte analyser (VetLyte; IDEXX Laboratories)
was used to measure K
+ and Na
+ concentrations. Post-challenge
data were compared with the mean data from the same group of
animals analysed pre-challenge.
Statistics. Pearson’s correlation analysis was used to determine the
relationship of gender, body weight, time to death and inhaled dose.
RESULTS AND DISCUSSION
The aim of this study was to examine disease progression
trends in marmosets following an inhalational challenge
with F. tularensis. Ethical considerations necessarily limited
group sizes, but the study design none the less provided
useful data. Animals were challenged with ~10
2 c.f.u. F.
tularensis and culled at specific time points post-challenge
(Table 1). Previous data have shown that marmosets
challenged in this dose range die between 4.5 and 7 days
post-challenge and that there is no statistical correlation
between the age, weight or gender of marmosets and
susceptibility to inhalational tularaemia (Nelson et al.,
2009). The course of infection was described in terms of
temperature profile, clinical signs of infection, cytokine
profile (data not shown), bacteriology (Fig. 1), immune cell
populations (Fig. 2), histopathology (Fig. 3), and haem-
atology and clinical parameters.
Early disease (0–48 h)
Mild pathological features, including mild enlargement of
the inter-alveolar septa, were observed in the lungs of one
animal culled immediately after challenge due to the
aerosol exposure process. Other minimal foci of inflam-
matory mononuclear cell infiltrations in the kidney and
liver were also considered to be background pathology.
During the early disease, animals appeared normal with no
apparent clinical signs or changes in behaviour and had a
normal Tc. On post-mortem, some slight haemorrhagic
lesions were apparent in the lungs of both animals at 24 h
post-challenge, which may have been as a result of the blood
withdrawal via cardiac puncture. There was no evidence of
gross pathology in any other organs. At 48 h post-challenge,
both animals exhibited splenomegaly, with slight hepato-
megaly in the male and enlarged lungs in the female. Minor
histopathology was observed in all these animal tissues, such
as small areas of emphysema in the lungs, as well as other
signs considered to be background histopathology.
At 24 h post-challenge, bacteria were recovered only from
the lungs of animals, with increasing numbers by 48 h
post-challenge, when there were also low levels of bacteria
recovered in the spleen (Fig. 1).
Baseline haematological and biochemical parameters for the
marmosets used in this study were comparable to previously
reported data (Yarbrough et al., 1984). Notable blood
parameter changes at 24 h post-challenge included: slightly
raised neutrophil percentage counts to 57.5% (but not total
white blood cell counts) compared with pre-challenge
baselines of 42%, a lowered platelet count to 434610
3 ml
21
(baseline value of 499610
3 ml
21) and significantly elevated
glucose concentrations to 340 mg dl
21 (baseline value of
197 mg dl
21), plus altered liver enzyme results (elevated ALT
to 89 U l
21 and elevated AST to 586 U l
21 compared with
baseline values of 11 and 134 U l
21, respectively). Changes in
blood parameters at 48 h post-challenge included elevated
bilirubin to 0.8 mg dl
21 (baseline value of 0.4).
Tularaemia pathogenesis in the common marmoset
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human antibodies were successfully used to detect and
identify marmoset cell types and cytokines as described
previously (Brok et al., 2001). Flow cytometry analysis
showed an increase in MCP-1 levels (not shown) and the
proportion of neutrophils in the lung at 24 h post-
Fig. 1. Bacterial load isolated from selected
marmoset organs at different times post-
challenge with ~10
2 c.f.u. inhalational F.
tularensis [n52 for all time points, except
terminal animals where n56 (samples
obtained from a previous study; Nelson et al.,
2009)].
Fig. 2. Cellular populations isolated from
selected marmoset organs at different times
after challenge with ~10
2 c.f.u. inhalational F.
tularensis [n52 for all time points, except naı ¨ve
control animals (baseline values) where n53].
(a) Lymphocyte populations in the lung. (b) T-
cell summary.
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the number of neutrophils in the lungs (Fig. 2a) and blood
(not shown) was observed to approximately 30%.
Increases in the percentages of NK cells and macrophages
(57 and 13%) were also observed in the lungs (and an
increase in T cells to 11%) (Fig. 2a), with an increase in T
and B cells in the spleen to 23 and 19%, respectively (not
shown). There was also an increase in the percentage of
CD8
+ T cells in the spleen and lungs to 13 and 11%,
respectively, with a slight increase in the proportion of
the cd T-cell population in the lung to approximately 3%
(Fig. 2b).
Overt disease (72 h onwards)
No overt clinical signs were apparent in any of the animals
until 96 h post-challenge, when they were subdued in
nature, with some slight piloerection. Animals that died
from infection or were culled due to severe infection
(between 4.5 and 7 days post-challenge) generally presented
with a progression of overt clinical signs of infection
including lethargy, piloerection, and unsteadiness or slow-
ness of movement (Nelson et al., 2009). The first indication
of infection in the marmoset is a rapid increase in body
temperature, which occurred in this study at 72 h post-
challenge. At this time, the mean Tc increased from 38.8 to
39.6 uC for the male and from38.5 to 40.4 uC for the female.
The temperatures continued to increase, and by 96 h post-
challenge the Tc of the animals remained consistently high
(greater than 40 uC) for at least 2 days. The time to onset of
fever in humans is similar and has been shown to occur at
3–6 days post-exposure (Evans et al., 1985; Saslaw et al.,
1961). The increase in temperature at this time in the
marmoset infection coincided with a number of other
factors. There was a rapid increase in the number of bacteria
isolated from all organs tested (Fig. 1), a more pronounced
gross pathology and histopathology, and an increase in the
immunological responses. The bacteria spread from the
lungs to the reticuloendothelial system (initially the spleen,
followed by the liver), with significant numbers in all organs
assessed at 96 h observed in the marmoset, as has also been
observed in murine and human infections (Conlan et al.,
2003; Gill & Cunha, 1997).
Histology. The small areas of lesions observed at earlier
times in the lung, liver, spleen and lymph tissue developed
Fig. 3. Haematoxylin and eosin-stained sections from marmosets infected with ~10
2 c.f.u. F. tularensis by the airborne route.
(a) Lung section from a marmoset at 72 h after challenge by the airborne route showing focal pneumonia. (b) Lung section from
a marmoset at 96 h post-challenge showing extensive bronchopneumonia. (c) Liver section from a marmoset at 96 h post-
challenge showing necrotizing hepatitis with the formation of microabscesses. (d) Spleen section from a marmoset at 96 h
post-challenge showing necrotizing splenitis with the formation of microabscesses. Magnification: 100 (a–c); 200 (d).
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pyogranulomatous pneumonia) by 72 h post-challenge
(Fig. 3a). This developed to pyogranulomatous pneumo-
nia in the lungs by 96 h, with multifocal to coalescent
inflammation apparent in one animal (Fig. 3b). Animals
also exhibited necrosis in the draining lymph nodes
(lymphadenitis), hepatitis, splenitis and interstitial pneu-
monia by 96 h post-challenge (Fig. 3c, d). The primary
infiltrating cell type was neutrophils, but lymphocytes,
macrophages and plasma cells were also identified. This
pathology, including pyogranulomatous pneumonia,
interstitial pneumonia, organ necrosis and the influx of
neutrophils and macrophages into tissue, is also seen in
human infection (Avery & Barnett, 1967; Martin & Marty,
2001; Syrjala et al., 1986). Other pathological features
reported in human infections were also observed in the
marmosets, including thrombosis, giant cells and lung
oedema (Martin & Marty, 2001; Syrjala et al., 1986).
Immunology. The type of immune response elicited by the
marmosets in response to F. tularensis infection was
indicated by the cytokine levels detected. Generally,
cytokine levels increased with disease progression, with
the highest levels in animals that were culled as a result of
severe infection (terminal animals). Levels of MCP-1 were
detected for the first time in the spleen, blood and lungs at
72 h post-challenge (1.1610
3, 1.15610
3 and 1610
3 pg
ml
21, respectively). The levels further increased in all
organs until just prior to death, reaching more than
5000 pg ml
21. By 96 h post-challenge, there was an
increase in the concentration of macrophage inflamma-
tory protein 1a (MIP-1a), MIP-1b, MCP-1, interleukin-6
(IL-6), RANTES and IL-1b present in all organs. The
presence of MIP-1a and IL-6 was first observed in animals
prior to death. The detection of IL-6 in animals shortly
before death is also observed in mice following inhalational
challenge (Conlan et al., 2008). The cytokine response
observed was consistent with the attraction of macro-
phages, immature dendritic cells, basophils and lympho-
cytes to sites of infection and the production of fever, sepsis
and tissue necrosis.
The first cell types to reach the sites of infection were the
neutrophils and NK cells at 24 h post-challenge, followed
by macrophages, NK cells and T cells at 48 h post-
challenge. By 72 h post-challenge, there was a decrease in
the percentage of neutrophils in the blood and lungs to 23
and 3%, respectively (Fig. 2a and data not shown), which
returned to within normal parameters by 96 h post-
challenge. The role of neutrophils in F. tularensis infection
is unclear; it has been shown that they are essential in
murine survival by reducing the bacterial burden in organs
(Sjo ¨stedt et al., 1994). This is despite evidence to suggest
that, although F. tularensis is readily taken up by
neutrophils, they are unable to kill the pathogen. This
study indicated that, despite a large increase in the
neutrophil population at 48 h post-challenge, there was
no apparent control of bacterial numbers; indeed, the
bacterial load in each organ tested rapidly increased after
this time. The rapid increase in the neutrophil population
reported here in the early response to tularaemia infection
has been shown in BALB/c mice in response to type B but
not type A strains (Hall et al., 2008). Failure of the F.
tularensis strain SCHU S4 to repress neutrophil recruit-
ment may reflect a basic difference between the murine and
a more resistant animal model, indicating that the
marmoset may provide a more representative model for
the human disease. The reduction in neutrophil numbers
at 72 h post-challenge may be due to the destruction of
these cells, particularly in the lungs.
At 72 h post-challenge, there was also a decrease in the
percentage of all cell types in the lungs including a decrease
in NK cells to 2%, and a decrease in T and B cells and
macrophage populations to less than 1% each (Fig. 2a).
There was an increase in the T and B cell populations in the
spleen to 27 and 29%, respectively, and also in the blood to
23 and 12% (data not shown). By 96 h post-challenge, the
percentage of most cell types had returned within normal
parameters in all organs (Fig. 2a and data not shown).
However, there was a further increase in the number of
CD8
+ T cells in the spleen and lung, and, most
interestingly, there was a large increase in the cd T-cell
population in these organs (Fig. 2b). cd T cells are known
to accumulate at sites of infection and are thought to act as
a first line of defence against certain intracellular patho-
gens. They have been linked repeatedly with Francisella
infections in humans (Kroca et al., 2000; Poquet et al.,
1998; Sumida et al., 1992). However, it is not clear whether
this increase is linked to survival or infection. In the
current study, there was no observable increase in the cd T-
cell population in the blood, although marked increases in
the spleen and lungs were observed. It is not surprising that
the cell numbers initially increased at the site of infection,
prior to circulation. Indeed, increases in the cd T-cell
population in the blood of patients suffering from
ulceroglandular tularaemia were not detected until 1 week
after infection (Kroca et al., 2000).
Blood parameters. Notable changes in the physiological
state of the animal included an increase in creatine kinase
levels at 72 h post-challenge, plus further evidence of
altered liver function (elevated AST in both animals, and
raised ALT in the female). By 96 h post-challenge, further
changes included elevated white blood cell counts to
14.3610
3 ml
21 from baseline values of 9.3610
3 ml
21,a
lowered platelet count in the male to 276610
3 ml
21 from
baseline values of 499610
3 ml
21 and significantly raised
plasma glucose and potassium to 685 mg dl
21 and
11.4 mmol l
21 from baseline levels of 197 mg dl
21 and
3.9 mmol l
21, respectively. In animals that died or were
culled due to severe infection, significantly reduced platelet
counts and plasma glucose concentrations were noted from
499610
3 ml
21 and 197 mg dl
21 to 49610
3 ml
21 and
29 mg dl
21, respectively. There were also significantly
elevated creatine kinase levels and raised levels of liver
M. Nelson and others
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creatininelevel.Thesechangesinbloodparameters,although
limited by the small number of animals studied at each time
point, were consistent with the onset of systemic infection.
Changes in plasma glucose, creatine kinase, liver function
enzymes and platelets, as well as no change to haemoglobin
levels, have been observed previously in tularaemia patients
(Evans et al., 1985; Kaiser et al., 1985).
In conclusion, experimental acute inhalational tularaemia
in the common marmoset appears to be representative of
the infection seen in humans. Clinical presentation,
bacterial spread, pathology and haematological, biochem-
ical and immunological changes (including increased cd T
cells) are similar between both species. These findings
suggest that the common marmoset may be a suitable
animal model of inhalational tularaemia, which may be
useful for the investigation of novel medical interventions
such as vaccines and therapeutics.
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